These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5631716)

  • 1. Lipid mobilisation during infusion of a posterior pituitary extract and lysine-8-vasopressin. I.- Plasma NEFA, glucose and 17-hydroxycorticosteroids levels in normal subjects and in patients with pituitary disorders.
    Piotti LE; Locatelli GR; Carullo P
    Folia Endocrinol; 1967 Oct; 20(5):611-25. PubMed ID: 5631716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lysine-vasopressin and adipokinesis in humans].
    Giordano G; Marcenaro A; Pompei A; Jacopino GE
    Arch Maragliano Patol Clin; 1970; 26(2):95-110. PubMed ID: 5537635
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the function of the hypothalamus-hypophysis-adrenal gland system tested with lysine-8-vasopressin. On lipolysis and the adrenal gland response in normal subjects and subjects treated with corticosteroids].
    Olivi O; Galli V; Balli F; Massolo F
    Clin Pediatr (Bologna); 1969 Feb; 51(2):61-77. PubMed ID: 5400419
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of lysine-vasopressin on the concentration of 11-hydroxycorticosteroids in the plasma of endocrine-well children, as test of pituitary function].
    Knebusch RE
    Helv Paediatr Acta; 1967 Aug; 22(4):376-89. PubMed ID: 4301677
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased urinary excretion of 32P after a single injection of extract from the posterior lobe of the hypophysis and after synthetic lysine-vasopressin in the relationship to the radiation disease.
    Kolousek J; Stojan B; Queisnerová M
    Neoplasma; 1966; 13(6):591-608. PubMed ID: 5973578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lysine vasopressin effects on free fatty-acid blood levels in patients with hypothalamo-hypophyseal syndromes].
    Klimek R; Paradysz A
    Rev Fr Endocrinol Clin; 1971; 12(1):57-62. PubMed ID: 5138160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intravenous administration of synthetic lysine-8-vasopressin and oxytocin. Effects on blood levels of growth hormone, follicle-stimulating hormone and insulin].
    Kleinknecht D; Rosselin G; Tchobroutsky G; Dolais J
    Presse Med (1893); 1969 May; 77(23):856-8. PubMed ID: 5806688
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperresponsiveness to lysine-vasopressin in Cushing's disease.
    Coslovsky R; Wajchenberg BL; Nogueira O
    Acta Endocrinol (Copenh); 1974 Jan; 75(1):125-32. PubMed ID: 4363841
    [No Abstract]   [Full Text] [Related]  

  • 9. [Variations of plasma lipid fractions under the influence of vasopressin in dogs].
    Dang Tran L; Despeyroux TM; Douste-Blazy L
    Bull Soc Chim Biol (Paris); 1968; 50(12):2495-501. PubMed ID: 5714495
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma growth hormone response to vasopressin: comparison with saline infusion in normal subjects and with insulin-induced hypoglycaemia in patients with intra- and suprasell tumours.
    Quabbe HJ
    Acta Endocrinol (Copenh); 1970 Feb; 63(2):359-77. PubMed ID: 5468630
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in blood glucose and plasma insulin, free fatty acids, growth hormone and 11-hydroxycorticosteroids during intramuscular vasopressin tests in children and adolescents.
    Karp M; Pertzelan A; Doron M; Kowadlo-Silbergeld A; Laron Z
    Acta Endocrinol (Copenh); 1968 Aug; 58(4):545-57. PubMed ID: 4878620
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic-inhibition effect of vasopressin].
    Ito S
    Nihon Naibunpi Gakkai Zasshi; 1967 Nov; 43(8):727-32. PubMed ID: 5626255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of plasma NEFA after arginine infusion. A simple test of the biological activity of STH?].
    Herrera Pombo JL; Larrodera L
    Rev Clin Esp; 1973 Jul; 130(2):111-6. PubMed ID: 4742337
    [No Abstract]   [Full Text] [Related]  

  • 14. The diurnal variation of urinary and plasma 17-hydroxy-corticosteroid (17-OHCS) levels and the plasma 17-OHCS response to lysine-8-vasopressin in depressive patients.
    Jakobson T; Blumenthal M; Hagman H; Heikkinen E
    J Psychosom Res; 1969 Dec; 13(4):363-75. PubMed ID: 4391347
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of lysine vasopressin on plasma free fatty acid level in obese women].
    Pawlikowski M; Piontek W
    Endokrynol Pol; 1972; 23(2):95-9. PubMed ID: 5030358
    [No Abstract]   [Full Text] [Related]  

  • 16. [The insulin test of the newborn. Study of blood sugar and plasmatic NEFA and 17-hydroxycortico-steroids].
    Falorni A; Angioni G; De Virgiliis S; Curreli A; Andria M
    Riv Clin Pediatr; 1967 Nov; 80(5):396-415. PubMed ID: 5607271
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on the adrenocorticotropic hormone. II. Studies on the mechanism of pituitary corticotropin secretion with synthetic lysine vasopressin].
    Mayama T
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):947-56. PubMed ID: 4298936
    [No Abstract]   [Full Text] [Related]  

  • 18. A phenylalanine-lysine-vasopressin test of ACTH release.
    Strott CA; Nakagawa K; Nankin H; Nugent CA
    J Clin Endocrinol Metab; 1967 Mar; 27(3):448-51. PubMed ID: 4290323
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressin test for corticotrophin release in man.
    Rinne UK; Nordström CG
    Med Pharmacol Exp Int J Exp Med; 1967; 17(6):543-56. PubMed ID: 4298779
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term hormonal effects on blood glucose and non-esterified fatty acids in female sheep.
    Luthman J; Jonson G
    Acta Vet Scand; 1972; 13(1):112-27. PubMed ID: 5023029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.